Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose R Quejada

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biophysical Journal|September 16, 2019
Detection of Na<sub>v</sub>1.5 Conformational Change in Mammalian Cells Using the Noncanonical Amino Acid ANAPMia A Shandell, Jose R Quejada, Masayuki Yazawa, et al.
Nucleic Acids Research|October 18, 2017
Optimized light-inducible transcription in mammalian cells using Flavin Kelch-repeat F-box1/GIGANTEA and CRY2/CIB1Jose R Quejada, Seon-Hye E Park, Daniel W Awari, et al.
Cell Reports Methods|April 27, 2022
GEM-IL: A highly responsive fluorescent lactate indicatorRamsey Bekdash, Jose R Quejada, Shunnosuke Ueno, et al.
Nature Cardiovascular Research|September 2, 2022
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndromeLouJin Song, Ramsey Bekdash, Kumi Morikawa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biophysical Journal|September 16, 2019
Detection of Na<sub>v</sub>1.5 Conformational Change in Mammalian Cells Using the Noncanonical Amino Acid ANAPMia A Shandell, Jose R Quejada, Masayuki Yazawa, et al.
Nucleic Acids Research|October 18, 2017
Optimized light-inducible transcription in mammalian cells using Flavin Kelch-repeat F-box1/GIGANTEA and CRY2/CIB1Jose R Quejada, Seon-Hye E Park, Daniel W Awari, et al.
Cell Reports Methods|April 27, 2022
GEM-IL: A highly responsive fluorescent lactate indicatorRamsey Bekdash, Jose R Quejada, Shunnosuke Ueno, et al.
Nature Cardiovascular Research|September 2, 2022
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndromeLouJin Song, Ramsey Bekdash, Kumi Morikawa, et al.
Pageof 1